UK Markets close in 2 hrs 45 mins

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
643.40-5.40 (-0.83%)
As of 2:44PM CEST. Market open.
Currency in DKK

Valuation measures

Market cap (intra-day) 51.48T
Enterprise value 31.47T
Trailing P/E 34.97
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)11.37
Price/book (mrq)25.40
Enterprise value/revenue 311.29
Enterprise value/EBITDA 724.96

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3684.50
52-week low 3406.90
50-day moving average 3641.29
200-day moving average 3526.01

Share statistics

Avg vol (3-month) 31.88M
Avg vol (10-day) 32.07M
Shares outstanding 51.76B
Implied shares outstanding 6N/A
Float 1.64B
% held by insiders 16.90%
% held by institutions 134.54%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 49.35
Forward annual dividend yield 41.45%
Trailing annual dividend rate 39.10
Trailing annual dividend yield 31.40%
5-year average dividend yield 42.45
Payout ratio 447.54%
Dividend date 3N/A
Ex-dividend date 416 Aug 2021
Last split factor 25:1
Last split date 302 Jan 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 34.15%
Operating margin (ttm)41.64%

Management effectiveness

Return on assets (ttm)22.98%
Return on equity (ttm)70.63%

Income statement

Revenue (ttm)129.91B
Revenue per share (ttm)56.11
Quarterly revenue growth (yoy)10.10%
Gross profit (ttm)106.01B
EBITDA 58.76B
Net income avi to common (ttm)44.36B
Diluted EPS (ttm)18.40
Quarterly earnings growth (yoy)14.10%

Balance sheet

Total cash (mrq)27.22B
Total cash per share (mrq)11.83
Total debt (mrq)13.76B
Total debt/equity (mrq)21.00
Current ratio (mrq)1.06
Book value per share (mrq)25.33

Cash flow statement

Operating cash flow (ttm)54.19B
Levered free cash flow (ttm)22.04B